Metabolic modeling-based drug repurposing in Glioblastoma.

Tomi-Andrino C, Pandele A, Winzer K, King J, Rahman R, Kim DH

Open source

DOI: 10.1038/s41598-022-14721-w
Published: 2022 Jul 1
Container: Scientific reports
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41598-022-14721-w,
  title = {Metabolic modeling-based drug repurposing in Glioblastoma.},
  author = {Tomi-Andrino C and Pandele A and Winzer K and King J and Rahman R and Kim DH},
  year = {2022},
  journal = {Scientific reports},
  doi = {10.1038/s41598-022-14721-w},
  url = {https://doi.org/10.1038/s41598-022-14721-w}
}

RIS

TY  - JOUR
TI  - Metabolic modeling-based drug repurposing in Glioblastoma.
AU  - Tomi-Andrino C
AU  - Pandele A
AU  - Winzer K
AU  - King J
AU  - Rahman R
AU  - Kim DH
PY  - 2022
JO  - Scientific reports
DO  - 10.1038/s41598-022-14721-w
UR  - https://doi.org/10.1038/s41598-022-14721-w
ER  -

APA

C, T., A, P., K, W., J, K., R, R., & DH, K. (2022). Metabolic modeling-based drug repurposing in Glioblastoma.. Scientific reports. https://doi.org/10.1038/s41598-022-14721-w

Source records

pubmed · retrieved 2026-09-25T21:06:03.479Z
europe-pmc · retrieved 2026-09-25T21:06:03.489Z
doaj · retrieved 2026-09-25T21:06:03.490Z